Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
Submitted by
admin
on July 21, 2024 - 11:02pm
Source:
Motley Fool
News Tags:
Pfizer
obesity
weight loss
Headline:
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
snippet:
Pfizer doesn't currently produce any anti-obesity medicines, but it wants to do so.
However, its most mature program on that front isn't exactly a sizzler.
It's also far behind the market's leaders in terms of its progress.
Do Not Allow Advertisers to Use My Personal information
